ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

AQST Aquestive Therapeutics Inc

3.28
-0.085 (-2.53%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Aquestive Therapeutics Inc AQST 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.085 -2.53% 3.28 09:00:00
개장가 저가 고가 종가 전일 종가
3.40 3.205 3.4099 3.28 3.365
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202420:00GLOBEAquestive Therapeutics Receives U.S. FDA Approval and Market..
25/04/202421:00GLOBEAquestive Therapeutics to Report First Quarter 2024..
13/04/202405:01GLOBEAquestive Therapeutics to Present Crossover Study Data for..
01/04/202421:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
25/03/202421:00GLOBEAquestive Therapeutics Announces Closing of Underwritten..
20/03/202410:49GLOBEAquestive Therapeutics Announces Pricing of $75 Million..
20/03/202405:01GLOBEAquestive Therapeutics Announces Proposed Public Offering of..
15/03/202406:23GLOBEAquestive Therapeutics Announces Pivotal Study for Anaphylm™..
11/03/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:14EDGAR2Form 144 - Report of proposed sale of securities
06/03/202407:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/03/202407:09EDGAR2Form 8-K - Current report
06/03/202407:05GLOBEAquestive Therapeutics Reports Full Year 2023 Financial..
21/02/202422:00GLOBEAquestive Therapeutics to Report Fourth Quarter 2023..
15/02/202422:00GLOBEAquestive Therapeutics to Present Anaphylm™ (epinephrine)..
15/02/202405:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/02/202407:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/01/202422:00GLOBEAquestive Therapeutics to Participate in Oppenheimer 34th..
09/12/202300:46EDGAR2Form 8-K - Current report
05/12/202322:51EDGAR2Form 8-K - Current report
05/12/202322:00GLOBEAquestive Therapeutics Doses First Patient in Phase 3..
10/11/202322:00GLOBEAquestive Therapeutics to Present Positive Data from..
09/11/202307:04EDGAR2Form 8-K - Current report
07/11/202307:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202307:20EDGAR2Form 8-K - Current report
07/11/202306:37GLOBEAquestive Therapeutics Reports Third Quarter 2023 Financial..
02/11/202321:45EDGAR2Form 8-K - Current report
02/11/202321:00GLOBEAquestive Therapeutics Completes $45 Million Debt..
31/10/202321:00GLOBEAquestive Therapeutics to Report Third Quarter 2023..
11/10/202301:04EDGAR2Form 8-K - Current report
09/10/202321:00GLOBEAquestive Therapeutics Provides Business Update
03/10/202305:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/10/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
21/09/202305:39EDGAR2Form 8-K - Current report
20/09/202323:57DJNAquestive Therapeutics Shares Rise 12% on Anaphylm Trial..
20/09/202322:04GLOBEAquestive Therapeutics Reaffirms Timeline and Pathway for..
11/09/202321:00GLOBEAquestive Therapeutics Receives FDA Acceptance of New Drug..
23/08/202321:00GLOBEAquestive Therapeutics to Participate in Two Upcoming..
12/08/202302:14EDGAR2Form 8-K - Current report
10/08/202306:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock